Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study

80Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Since February 21 2020, when the Italian National Institute of Health (Istituto Superiore di Sanità–ISS) reported the first autochthonous case of infection, a dedicated surveillance system for SARS-CoV-2-positive (COVID+) cases has been created in Italy. These data were cross-referenced with those inside the Information Transplant System in order to assess the cumulative incidence (CI) and the outcome of SARS-COV-2 infection in solid organ transplant recipients (SOTRs) who are assumed to be most at risk. We compared our results with those of COVID+ nontransplanted patients (Non-SOTRs) with follow-up through September 30, 2020. The CI of SARS-CoV-2 infection in SOTRs was 1.02%, higher than in COVID+ Non-SOTRs (0.4%, p

Cite

CITATION STYLE

APA

Trapani, S., Masiero, L., Puoti, F., Rota, M. C., Del Manso, M., Lombardini, L., … Feltrin, G. (2021). Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study. American Journal of Transplantation, 21(7), 2509–2521. https://doi.org/10.1111/ajt.16428

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free